Cytokinetics Wins UK Approval for MYQORZO in oHCM
SOUTH SAN FRANCISCO, Calif., July 30, 2026 Cytokinetics, Incorporated has achieved a major regulatory and market access milestone for...
cardiovascular disease
Advertisement
Amgen’s Repatha Wins CHMP Support for Broader Heart Protection
THOUSAND OAKS, Calif., July 29, 2026 Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP)...
Novo Nordisk Reports ZEUS Phase 3 Results for Ziltivekimab
BAGSVÆRD, Denmark, July 31, 2026 Novo Nordisk announced headline results from the Phase 3 ZEUS cardiovascular outcomes trial evaluating...
Seegene Expands Precision Diagnostics for Women’s Health
SEOUL, South Korea, July 27, 2026 Seegene Inc., a global leader in molecular diagnostics, has introduced a comprehensive syndromic...
Alamar Biosciences Launches NULISAseq Immune 340 Panel
FREMONT, Calif., July 28, 2026 Alamar Biosciences, Inc. has announced the commercial launch of the NULISAseq™ Immune 340 Panel,...
Advertisements
Lexicon Pharmaceuticals Completes Enrollment in Phase 3 SONATA-HCM Trial
THE WOODLANDS, Texas, July 27, 2026 Lexicon Pharmaceuticals, Inc. announced the completion of patient enrollment and randomization in the...
AnX Robotica Unveils NaviCONNECT Cloud Platform for GI Diagnostics
PLANO, Texas, July 26, 2026 AnX Robotica has announced the commercial launch of NaviCONNECT™, a next-generation cloud platform designed...
NewAmsterdam Pharma Wins CHMP Support for Ubeslo® and Evlarco®
NAARDEN, The Netherlands; MIAMI, USA; and FLORENCE, Italy, July 24, 2026 NewAmsterdam Pharma and its commercialization partner Menarini Group...
Eli Lilly Reports Positive Phase 3 Retatrutide Results
INDIANAPOLIS, July 23, 2026 Eli Lilly and Company has announced positive topline results from the Phase 3 TRIUMPH-2 and...
ArkBio Completes Phase I Dosing of AK0406 Influenza Drug
SHANGHAI, July 23, 2026 ArkBio has successfully completed dosing across all cohorts in its Australian Phase I clinical trial...
Advertisement
